卫生研究

参考文献

[1]薛小燕,郭小华,李敏,等.神经退行性疾病的药物治疗研究[J].中国老年学杂志,2014(6):1704-1707.

[2]DAVID S,KEITH K.Synergistic action of microglia and astrocytes in the progession of alzeimer’s disease[J].J Alzeimer’s Dis,2015,45(4):1001-1014.

[3]CHOI J,ZHENG Q,KATZ H E,et al.Silica-based nanoparticle uptake and cellular response by primary microglia[J].Environ Health Perspect,2010,118(5):589-595.

[4]NIMMERJAHN A,KIRCHHOFF F,HELMCHEN F.Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo[J].Science,2005,308(5726):1314-1318.

[5]RANSOHOFF R M,NEUROSCIENCE S B.How many cell types does it take to wire a brain[J].Science,2011,333(6048):1391-1392.

[6]CAMERON B,LANDRETH G E.Inflammation,microglia,and Alzheimer’s disease[J].Neurobiol Dis,2010,37(3):503-509.

[7]边艳青,黄翠,赵宝华.小胶质细胞功能状态的研究进展[J].免疫学杂志,2012(2):174-176.

[8]WU Z,NAKANISHI H.Connection between periodontitis and Alzheimer’s disease:possible roles of microglia and leptomeningeal cells[J].J Pharmacol Sci,2014,126(1):8-13.

[9]MOSHER K I,WYSS-CORAY T.Microglial dysfunction in brain aging and Alzheimer’s disease[J].Biochem Pharmacol,2014,88(4):594-604.

[10]苏新辉,豆晓锋,张亚飞,等.小胶质细胞在神经退行性疾病发生发展中的双重作用[J].解剖学研究,2013(3):220-224.

[11]FERRERA D,MAZZARO N,CANALE C,et al.Resting microglia react to Abeta42 fibrils but do not detect oligomers or oligomer-induced neuronal damage[J].Neurobiol Aging,2014,35(11):2444-2457.

[12]BOLMONT T,HAISS F,EICKE D,et al.Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance[J].J Neurosci,2008,28(16):4283-4292.

[13]PARK L,ZHOU J,ZHOU P,et al.Innate immunity receptor CD36 promotes cerebral amyloid angiopathy[J].Proc Natl Acad Sci U S A,2013,110(8):3089-3094.

[14]何晓,孙秉贵.小胶质细胞及免疫相关受体在老年痴呆症中的作用研究进展[J].药学学报,2014(6):774-780.

[15]PICKFORD F,MASLIAH E,BRITSCHGI M,et al.The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloidβaccumulation in mice[J].J Clin Invest,2008,118(6):2190-2199..

[16]YANG C N,SHIAO Y J,SHIE F S,et al.Mechanism mediating oligomeric Abeta clearance by naive primary microglia[J].Neurobiol Dis,2011,42(3):221-230.

[17]KONISHI A,ARAKAWA S,YUE Z,et al.Involvement of Beclin 1 in engulfment of apoptotic cells[J].J Biol Chem,2012,287(17):13919-13929.

[18]LUCIN K M,O’BRIEN C E,BIERI G,et al.Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer’s disease[J].Neuron,2013,79(5):873-886.

[19]DERETIC V,LEVINE B.Autophagy,immunity,and microbial adaptations[J].Cell Host Microbe,2009,5(6):527-549.

[20]JAEGER P A,PICKFORD F,SUN C H,et al.Regulation of amyloid precursor protein processing by the Beclin 1 complex[J].PLo S One,2010,5(6):e11102.

[21]MANDREKAR S,JIANG Q,LEE C Y,et al.Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis[J].JNeurosci,2009,29(13):4252-4262.

[22]HENEKA M T,KUMMER M P,STUTZ A,et al.NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice[J].Nature,2013,493(7434):674-678.

[23]GERTIG U,HANISCH U K.Microglial diversity by responses and responders[J].Front Cell Neurosci,2014,8:101.

[24]BHASKAR K,MAPHIS N,XU G,et al.Microglial derived tumor necrosis factor-alpha drives Alzheimer’s disease-related neuronal cell cycle events[J].Neurobiol Dis,2014,62:273-285.

[25]MALM T M,JAY T R,LANDRETH G E.The evolving biology of microglia in Alzheimer’s disease[J].Neurotherapeutics,2015,12(1):81-93.

[26]汪明玉,刘志辉,孙杨.小胶质细胞在帕金森病发病中的作用机制[J].临床神经病学杂志,2014(3):230-231.

[27]QIAN L,FLOOD P M,HONG J S.Neuroinflammation is a key player in Parkinson’s disease and a prime target for therapy[J].J Neural Transm,2010,117(8):971-979.

[28]THEODORE S,CAO Shuwen,Mc LEAN-PAMELA,et al.Targeted ocerexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease[J].J Neuropathol Exp Neurol,2008,67(12):1149-1158.

[29]OUCHI Y,YAGI S,YOKOKURA M,et al.Neuroinflammation in the living brain of Parkinson’s disease[J].Parkinsonism Relat Disord,2009,15(Suppl 3):200-204.

[30]HUH S H,CHUNG Y C,PIAO Y,et al.Ethyl pyruvate rescues nigrostriatal dopaminergic neurons by regulating glial activation in a mouse model of Parkinson’s disease[J].J Immunol,2011,187(2):960-969.

[31]KOZIOROWSKI D,TOMASIUK R,SZLUFIK S,et al.Inflammatory cytokines and NT-pro CNP in Parkinson’s disease patients[J].Cytokine,2012,60(3):762-766.

[32]STONE D K,REYNOLDS A D,MOSLEY R L,et al.Innate and adaptive immunity for the pathobiology of Parkinson’s disease[J].Antioxid Redox Signal,2009,11(9):2151-2166.

[33]KUMAR H,LIM H W,MORE S V,et al.The role of free radicals in the aging brain and Parkinson’s disease:convergence and parallelism[J].Int J Mol Sci,2012,13(8):10478-10504.

[34]BEERS D R,ZHAO W,LIAO B,et al.Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice[J].Brain Behav Immun,2011,25(5):1025-1035.

[35]RAIVICH G.Like cops on the beat:the active role of resting microglia[J].Trends Neurosci,2005,28(11):571-573.

[36]QIN Liya,LIU Yuxin,HONG J S,et al.NADPH oxidase and aging drive microglial activation,oxidative stress and dopaminergic neurodegeneration following systemic LPS administration[J].Glia,2013,61(6):855-868.